Please assess the completion status of the following clinical trial:

Trial Title: Desmopressin Melt: Impact on Sleep and Daytime Functioning

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* New patient~* age 6 to 16 years~* monosymptomatic nocturnal enuresis, nocturnal polyuria and sleep problems~Exclusion Criteria:~* mental retardation~* autism spectrum disorders~* daytime incontinence resistant to therapy~* dysfunctional voiding~* poor therapy-compliance~* diuretics, antihypertensives, uropathy, renal abnormalities

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- Desmopressin lyophilisate (Melt) (Type: EXPERIMENTAL): Patients receiving Desmopressin lyophilisate (Melt).

Based on this trial design, predict the completion outcome and termination type (if applicable).